Sorry, you need to enable JavaScript to visit this website.
    Pfizer Press release

Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizer's Proposed Acquisition of Hospira

Pfizer will hold an analyst and investor call to discuss its proposed acquisition of Hospira at 9:00 AM EST (2:00 PM GMT) today, February 5, 2015.

Pfizer will also hold a media call at 10:15 AM EST (3:15 PM GMT) today, February 5, 2015.

The information to access the calls can be found below.
 

 

INVESTOR / ANALYST CALL
February 5, 2015
9.00 AM EST / 2.00 PM GMT

 

Participant Dial in:

Participant Toll-Free Dial-In Number: (877) 409-7641
Participant International Dial-In Number: (631) 485-4301
Password: Analyst Call

Webcast link:
http://www.visualwebcaster.com/event.asp?id=101579
 

 


MEDIA CALL
February 5, 2015
10:15 AM EDT / 3:15 PM GMT

 

Participant Dial in:

Participant Toll-Free Dial-In Number: (877) 884-4775
Participant International Dial-In Number: (631) 485-4564
Password: Media Call

Webcast link:
http://www.visualwebcaster.com/event.asp?id=101584

Pfizer Inc.

Media Relations:

Joan Campion, 212-733-2798
Andrew Topen, 212-733-1338

or
 

Investor Relations:

Chuck Triano, 212-733-3901

 


 

Hospira, Inc.

Media Relations:

Stacey Eisen, 224-212-2357

Or
 

Investor Relations:

Karen King, 224-212-2711

Sign up for the latest Pfizer Wire news alerts

Receive real-time updates on Pfizer’s news delivered directly to your inbox.

Our Pipeline: Potential Breakthroughs in the Making

We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

Corporate Fact Sheet

For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

Media Asset Library

Click here to view our media asset library.

Pfizer Logo

Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

Executive Leadership

Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

Stay up to date on the latest news and alerts through the Pfizer Wire

Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

 

Sign Up Now